Page 9

tive. Today Agappe is proud to announce the launch of 4th generation Fully automated specific protein system in Oct 2018. Our mission is to expand and continuously improve our products and services and always look for new opportunities and provide innovative and affordable solutions to become the best partner in diagnostics. The IVD testing can be divided in to Pre-analytical, Analytical and Post Analytical stages. Where pre-analytical stage is the phase where the sampling is performed, analytical stage where the tests are performed and post analytical stage where the reporting is done. When you look at the current scenario, introduction or im-

"Our mission is to expand and continuously improve our products and services and always look for new oppor tunities and provide innovative and affordable solutions to become the best partner in diagnostics".

provement is always happening majorly in the analytical sector. Today analytical automation systems are available from 60 Tests/ hour to 2000 Tests/ hour covering the complete range of IVD testing. The multinationals and Indian manufacturers are doing their best to provide compact and affordable systems in Clinical Chemistry, Immuno-chemistry and Haematology automation. This is one of the reason for the exponential growth in the entry level clinical chemistry automation in India. Today highly affordable systems are available in the haematology segment, thanks to the advancements of electronics, imaging, microfluidics, mechanics and information technology. When we consider the analytical stage, there are multiple check points starting from Internal Quality Control (IQC)testing and peer group testing to assure the quality of the tests performed. The major concern in the Clinical laboratory is to control the pre-analytical errors (majorly sampling errors). It is estimated that 70% of the error in the clinical diagnosis is due to pre-analytical variables. This is mainly due to human errors that can crept in when the blood is taken, transferred to the test tube and labelling is done. In Indian scenario, the highest population of testing is performed in the class B and C (middle and small) laboratories where 60% of the total tests in IVD are performed. This segment accounts to more than 25,000 laboratories, which is approximately half of the total laboratories in India. Due to the lack of pre-analytical automation, these laboratories are spending more time and money to assure the test quality which in

TECHAGAPPE

APRIL-JUNE 2018

9

Techagappe 15th edition (April - June 2018) E-book  

Agappe Diagnostics Limited is the first Indian IVD company publishing an International Diagnostic News Journal “Techagappe” for the public t...

Techagappe 15th edition (April - June 2018) E-book  

Agappe Diagnostics Limited is the first Indian IVD company publishing an International Diagnostic News Journal “Techagappe” for the public t...

Advertisement